Biomarker R&D program(Page)
Biomarker R&D program Preclinical Arrow Medicortex has performed preclinical research. The results showed some unique biomarkers released as b...

Medicortex Finland Is Developing Diagnostic Tool Based on Biomarkers for Traumatic Brain Injury and Stroke(News)
d research to establish a biomarker and to develop a diagnostic test that would reliably establish the severity and extent of brain injury. An...

Medicortex was granted a European patent for biomarker diagnostics(News)
Medicortex's biomarker diagnostics patent “A Method for Determining a Lectin-binding Glycan Indicative to Traumatic Brain Injury”...

A New Clinical Trial for a Novel Brain Injury Biomarker(News)
-for-a-novel-brain-injury-biomarker.html" class="aloha-link-text" target="_blank">Press release in English--Varsinais-Suomen saira...

Results of the First Clinical Study are Published in Frontiers in Biomarkers of Brain Injury(News)
l issue, the Frontiers in Biomarkers of Brain Injury of the Brain Sciences journal. The article summarizes results from the first clinical stu...

Proof of concept(Page)
esults showed some unique biomarkers released as biodegradation products after head injury. The data served as the basis and confirmation for ...

Why Invest?(Page)
ents: Our groundbreaking biomarker is fully protected by patents. These patents not only signify our commitment to innovation but also provi...

Traumatic brain injury (Page)
f TBI, such as the use of biomarkers to supplement diagnosis. An alarming number of people fail to get a proper TBI diagnosis . Failing to dia...

Business Strategy(Page)
ficient. A quick and easy biomarker test based on one of the body fluids would help doctors in the diagnosis in emergency response situations....

Articles(Page)
published in Frontiers in Biomarkers of Brain Injury. Kvist Et Al 2021 Glycans As Potential Diagnos A review article compiled by the Medicorte...

Technology(Page)
A biomarker diagnostic test for TBI may be of use in identifying individuals with TBI, who are at risk of secondary brain injury and therefore...

Why invest?(Page)
. Our test – detecting a biomarker in a non-invasive sample (urine or saliva) – will address a TBI point of care (POC) diagnostics market tha...

Second clinical trial(Page)
d for the precence of the biomarker.  Sample analysis showed statistically significant increase in biomarker level.  2nd Clinical Trial Pictur...

Product to be Developed(Page)
of Traumatic Brain Injury biomarkers. The test will be developed in collaboration with Fepod Oy Ltd who have patented the technology for blood...

Company Profile(Page)
based on the proprietary biomarker we have studied in several clinical trials. Medicortex Finland is dedicated to improving the diagnostics a...

IP rights(Page)
Patent portfolio Biomarker and diagnostics portfolio 1. Prognostic and Diagnostic Glycan-based Biomarkers of Brain Damage European patent No. ...

Company Profile(Page)
based on the proprietary biomarker we have studied in several clinical trials. In parallel, Medicortex proposes development of a quantitative...

Letter from CEO(Page)
sed on unique proprietary biomarkers released as biodegradation products upon brain injury, detected from a non-invasive body fluid sample (ur...

Letter from CEO(Page)
sed on unique proprietary biomarkers released as biodegradation products upon brain injury, detected from non-invasive samples (urine and sali...

A review article was published(News)
he latest research on TBI biomarkers. The article was published in a peer-reviewed journal eNeuro in the December 2016 issue. You can have acc...

A utility patent was approved for Medicortex in China(News)
rement of our proprietary biomarker we found from patients with a concussion.This is the second patent that has been granted to Medicortex...

Patent granted in Israel(News)
d Diagnostic Glycan-Based Biomarkers of Brain Damage”, was granted in Israel (IL patent number 254980). The patent is pivotal in protecting th...

Third clinical trial (Page)
aimed to demonstrate the biomarker feasibility to detect concussion in head injured children. Third clinical trial...

Press releases(Page)
n patent for detection of biomarker indicative to brain injury" - published 24.1.2024. "Business Finland supporting Medicortex" - published 15...

Tietoa meistä(Page)
osaavan tiimimme voimin. Biomarker Photo From Army Video Kansainvälinen tarve luo hedelmällisen markkinan Vastaamme kehitystyöllämme maailman...

Drug development program(Page)
ently focusing on the TBI biomarker R&D project Because secondary brain injury is caused by multiple cascades of biochemical reactions, previo...

Immateriaalioikeudet(Page)
d Diagnostic Glycan-based Biomarkers of Brain Damage” Euroopan patentti No. 3283880 Kanadan patentti No. 2,982,503 USA:n patentti No. 10,739,3...

Lehdistötiedotteet(Page)
n patent for detection of biomarker indicative to brain injury"  - julkaistu 24.1.2024. "Business Finland tukee Medicortexia" - julkaistu 15.1...

The TBI Market(Page)
is currently developing a biomarker-based diagnostic test for detection of mTBI. The hand-held test is rapid, can be used at the point-of-inju...

Art Helping TBI Research(News)
y diagnostic kit based on biomarkers and in the future developing a drug.Additional artists willing to take part and help this importan...

The First Clinical Trial is Approaching(News)
he profiles of the unique biomarkers will be studied and compared between head injured patients and healthy volunteers. The study will be perf...

Dr. Harel presenting at ESTES Congress 2017(News)
The abstract "New biomarker for traumatic brain injury" was selected for oral presentation. Dr. Harel will give the presentation in th...

Clinical Trial Result Marks a Significant Accomplishment for Medicortex Finland(News)
stic potential of the new biomarker test in humans with brain injury and they confirm the findings we had in our preclinical studies. This is...

An interview published(News)
com/author-interviews/new-biomarker-has-potential-for-sideline-diagnosis-of-traumatic-brain-injury/36254/" class="aloha-link-text" target="_bl...

Scientific advisory board gather together first time in a new composition (News)
ive discussion around TBI biomarkers and Medicortex role in this exiting area. We feel that the active discussion and exchange of ideas is ben...

Medicortex featuring in a premium magazine(News)
xt" target="_blank">Using Biomarkers to Supplement the Diagnosis of Traumatic Brain Injuries ...

Scientific and Clinical Advisory Board meeting / tieteellis-kliininen toimikuntakokous (News)
a new indication for the biomarker was discussed. Medicortexin tieteellis-kliininen toimikunta kokoontui 10. kesäkuuta. Toimi...

Major achievement – A patent was issued in the United States (News)
d innovative brain injury biomarker. ...

Completion of the Third Clinical Trial - an Important Achievement for Medicortex Finland(News)
he presence of the unique biomarkers for traumatic brain injuries. ...

Patent issued in Canada / Patentti myönnetty Kanadassa(News)
or our core technology in biomarker diagnostics. Please see the...

Medicortex has published a company release announcing that the US Department of Defense has approved Company’s project plan(News)
ip detecting brain injury biomarkers in urine. The Company starts negotiations for a research grant of up to 2 million dollars...

Medicortex Finland Oy Announces Issuance of a Patent for Brain Injury Biomarker(News)
European Patent Office (EPO) has issued a patent covering a new diagnostic kit technology...

Home(Page)
Home ABI,Biomarker,TBI...